Rare Cancers together comprise 20% of all cancers
Patient survival is worse than common cancers
Innovation means investment into action.
Innovative actions will improve the outcomes for patients and their families.
The EIT Health Rare Cancer project was launched in 2016 with one aim; to generate a team to promote innovative systems-based solutions to the benefit of the patient.Learn More
On behalf of the Organising Committee, we would like to thank you for attending the 2nd EURACAN Conference organised in collaboration with EIT Health. Professors Bass Hassan and Jean-Yves Blay showcase the EURACAN 2nd Annual Conference held at the Examination Schools at the University of Oxford on 4th – 6th April, 2018. For the first time, Academics, […]
As rare cancers are currently affecting around half a million people's lives in Europe, responding to the unmet needs is a societal priority.Learn More
The Rare Cancer Project team with their collaborators in industry and academia are trying to bring novel ideas and plans to reality.Meet the team